STERIS plc

NYSE STE

Download Data

STERIS plc Market Capitalization on April 12, 2024: USD 20.16 B

STERIS plc Market Capitalization is USD 20.16 B on April 12, 2024, a 4.65% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • STERIS plc 52-week high Market Capitalization is USD 23.32 B on February 22, 2024, which is 15.70% above the current Market Capitalization.
  • STERIS plc 52-week low Market Capitalization is USD 17.95 B on April 25, 2023, which is -10.94% below the current Market Capitalization.
  • STERIS plc average Market Capitalization for the last 52 weeks is USD 21.37 B.
SV Wall Street

Don’t Miss A Beat

Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.

NYSE: STE

STERIS plc

CEO Mr. Daniel A. Carestio
IPO Date June 1, 1992
Location Ireland
Headquarters 70 Sir John Rogerson?s Quay, Dublin, Ireland, D02 R296
Employees 17,000
Sector Healthcare
Industry Medical devices
Description

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Similar companies

OFIX

Orthofix Medical Inc

USD 13.32

-4.52%

IRTC

iRhythm Technologies Inc

USD 113.19

-1.44%

StockViz Staff

April 14, 2024

Any question? Send us an email